1966 related articles for article (PubMed ID: 28595531)
1. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
2. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
Kumar S; Chowdhury S; Kumar S
BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
[TBL] [Abstract][Full Text] [Related]
3. Repurposed agents in the Alzheimer's disease drug development pipeline.
Bauzon J; Lee G; Cummings J
Alzheimers Res Ther; 2020 Aug; 12(1):98. PubMed ID: 32807237
[TBL] [Abstract][Full Text] [Related]
4. Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer's disease.
Jojo GM; Kuppusamy G
J Clin Pharm Ther; 2019 Jun; 44(3):337-348. PubMed ID: 30738020
[TBL] [Abstract][Full Text] [Related]
5. Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood.
Bourdakou MM; Fernández-Ginés R; Cuadrado A; Spyrou GM
Redox Biol; 2023 Nov; 67():102881. PubMed ID: 37696195
[TBL] [Abstract][Full Text] [Related]
6. Repackaging FDA-approved drugs for degenerative diseases: promises and challenges.
Cummings JL; Zhong K
Expert Rev Clin Pharmacol; 2014 Mar; 7(2):161-5. PubMed ID: 24502586
[TBL] [Abstract][Full Text] [Related]
7. Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
Zhang M; Schmitt-Ulms G; Sato C; Xi Z; Zhang Y; Zhou Y; St George-Hyslop P; Rogaeva E
PLoS One; 2016; 11(12):e0168812. PubMed ID: 28005991
[TBL] [Abstract][Full Text] [Related]
8. Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.
Bayraktar A; Li X; Kim W; Zhang C; Turkez H; Shoaie S; Mardinoglu A
J Transl Med; 2023 May; 21(1):332. PubMed ID: 37210557
[TBL] [Abstract][Full Text] [Related]
9. Topical Discoveries on Multi-Target Approach to Manage Alzheimer's Disease.
Batool A; Kamal MA; Rizvi SMD; Rashid S
Curr Drug Metab; 2018; 19(8):704-713. PubMed ID: 29512457
[TBL] [Abstract][Full Text] [Related]
10. Medical genetics-based drug repurposing for Alzheimer's disease.
Zhang XZ; Quan Y; Tang GY
Brain Res Bull; 2015 Jan; 110():26-9. PubMed ID: 25446738
[TBL] [Abstract][Full Text] [Related]
11. A review: treatment of Alzheimer's disease discovered in repurposed agents.
Appleby BS; Nacopoulos D; Milano N; Zhong K; Cummings JL
Dement Geriatr Cogn Disord; 2013; 35(1-2):1-22. PubMed ID: 23307039
[TBL] [Abstract][Full Text] [Related]
12. Old Drugs with New Tricks: Paradigm in Drug Development Pipeline for Alzheimer's Disease.
Dalvi T; Dewangan B; Das R; Rani J; Shinde SD; Vhora N; Jain A; Sahu B
Cent Nerv Syst Agents Med Chem; 2020; 20(3):157-176. PubMed ID: 33087034
[TBL] [Abstract][Full Text] [Related]
13. Drug Repositioning for Alzheimer's Disease: Finding Hidden Clues in Old Drugs.
Ihara M; Saito S
J Alzheimers Dis; 2020; 74(4):1013-1028. PubMed ID: 32144994
[TBL] [Abstract][Full Text] [Related]
14. Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases.
Lanza V; Milardi D; Di Natale G; Pappalardo G
Curr Med Chem; 2018 Feb; 25(4):525-539. PubMed ID: 28521682
[TBL] [Abstract][Full Text] [Related]
15. Repurposing Licensed Drugs for Use Against Alzheimer's Disease.
Norins LC
J Alzheimers Dis; 2021; 81(3):921-932. PubMed ID: 33843684
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics methods in drug repurposing for Alzheimer's disease.
Siavelis JC; Bourdakou MM; Athanasiadis EI; Spyrou GM; Nikita KS
Brief Bioinform; 2016 Mar; 17(2):322-35. PubMed ID: 26197808
[TBL] [Abstract][Full Text] [Related]
17. Discovering new treatments for Alzheimer's disease by repurposing approved medications.
Appleby BS; Cummings JL
Curr Top Med Chem; 2013; 13(18):2306-27. PubMed ID: 24059463
[TBL] [Abstract][Full Text] [Related]
18. Recent Trends in the Management of Alzheimer's Disease: Current Therapeutic Options and Drug Repurposing Approaches.
Singh RK
Curr Neuropharmacol; 2020; 18(9):868-882. PubMed ID: 31989900
[TBL] [Abstract][Full Text] [Related]
19. How nano-engineered delivery systems can help marketed and repurposed drugs in Alzheimer's disease treatment?
Séguy L; Groo AC; Malzert-Fréon A
Drug Discov Today; 2022 Jun; 27(6):1575-1589. PubMed ID: 35227886
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic strategies for tauopathies and drug repurposing as a potential approach.
Islam M; Shen F; Regmi D; Du D
Biochem Pharmacol; 2022 Apr; 198():114979. PubMed ID: 35219701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]